| Identification | Back Directory | [Name]
2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]phenoxy]-N-methyl- | [CAS]
2098799-13-2 | [Synonyms]
3,4-bis CTF- Carbomylamine PMA Regorafenib
Regorafenib (1-(4-Chloro-3-(trifluoromethyl)phenyl)urea)dimer
2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]phenoxy]-N-methyl- | [Molecular Formula]
C35H23Cl2F7N6O5 | [MDL Number]
MFCD28359383 | [MOL File]
2098799-13-2.mol | [Molecular Weight]
811.49 |
| Hazard Information | Back Directory | [Uses]
4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)phenoxy)-N-methylpicolinamide is a derivative/impurity of Regorafenib(R143000). Regorafenib is an inhibitor of PDGFR tyrosine kinase; an anti-proliferative agent used in the treatment of inflammation and a dual action VEGFR & Raf inhibitor. |
|
|